|
1
|
Li N, Lu B, Luo C, Cai J, Lu M, Zhang Y,
Chen H and Dai M: Incidence, mortality, survival, risk factor and
screening of colorectal cancer: A comparison among China, Europe,
and northern America. Cancer Lett. 522:255–268. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sharma R, Abbasi-Kangevari M, Abd-Rabu R,
Abidi H, Abu-Gharbieh E, Acuna JM, Adhikar S, Advan SM, Sohail
Afzal M, Meybodi MA, et al: Global, regional, and national burden
of colorectal cancer and its risk factors, 1990–2019: A systematic
analysis for the Global Burden of Disease Study 2019. Lancet
Gastroenterol Hepatol. 7:627–647. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ruff SM, Brown ZJ and Pawlik TM: A review
of targeted therapy and immune checkpoint inhibitors for metastatic
colorectal cancer. Surg Oncol. 51:1019932023. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fuhong D, Xiang G, Haiying L, Jiangye W,
Xueming G and Wenxiao C: Evaluation of efficacy and safety for
Brucea javanica oil emulsion in the control of the malignant
pleural effusions via thoracic perfusion. BMC Cancer. 18:4112018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang X, Wang H, Cao L, Wu J, Lu T, Li S
and Li J: Efficacy and safety of Brucea Javanica oil
emulsion injection in the treatment of gastric cancer: A systematic
review and meta-analysis. Front Nutr. 8:7841642021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen J, Chen S, Yang X, Wang S and Wu W:
Efficacy and safety of Brucea javanica oil emulsion
injection as adjuvant therapy for cancer: An overview of systematic
reviews and meta-analyses. Phytomedicine. 102:1541412022.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou H, Wang Q, Jiao L, Bi L, Sang S, Han
Y, Gan S, Liu R, AG and Gong Y: Intrapleural injection of Brucea
javanica oil emulsion provided a long-term benefits in patient
with malignant pleural effusion from pleural mesothelioma: A case
report. Explore (NY). 20:126–129. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ye L, Zhao JF, Wang YM, Chen WH, Qian S,
Zhou ZG and Xu M: Brucea javanica oil emulsion suppresses
tumor growth in human cervical cancer cells through inhibition of
the E6 oncogene and induction of apoptosis. Transl Cancer Res.
9:918–929. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Y, Chen B, Xiao M, Wang X and Peng Y:
Brucea javanica oil emulsion promotes autophagy in ovarian
cancer cells through the miR-8485/LAMTOR3/mTOR/ATG13 signaling
axis. Front Pharmacol. 13:9351552022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang H, Yin SL, Wang LH, Jia LN, Su GY,
Liu XQ, Zhou F, Breslin P, Meng R, Li QY, et al: Seed oil of
Brucea javanica induces apoptosis through the PI3K/Akt
signaling pathway in acute lymphocytic leukemia Jurkat cells. Chin
J Nat Med. 19:608–620. 2021.PubMed/NCBI
|
|
11
|
Meng J, Yu Z, Chen H, Yu X, Jiang M, Zeng
XA and You J: Brucea javanica oil emulsion significantly
improved the effect of anti-programmed cell death protein-1
immunotherapy. Phytomedicine. 107:1544462022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pan P, Yang BX and Ge XL: Brucea
javanica seed oil enhances the radiosensitivity of esophageal
cancer by inhibiting hypoxia-inducible factor 1α, in vitro and in
vivo. Oncol Lett. 15:3870–3875. 2018.PubMed/NCBI
|
|
13
|
Shi R, Wu Z, Wang H, Zhang J, Zhang F,
Stalin A, Chen M, Huang J, Zhai Y, Zhang Q, et al: Investigation on
the efficiency of Brucea javanica oil emulsion injection
with chemotherapy for treating malignant pleural effusion: A
meta-analysis of randomized controlled trials. Front Pharmacol.
13:9982182022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang M, Shen C, Zhu SJ, Zhang Y, Jiang HL,
Bao YD, Yang GY and Liu JP: Chinese patent medicine Aidi injection
for cancer care: An overview of systematic reviews and
meta-analyses. J Ethnopharmacol. 282:1146562022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang T, Nan H, Zhang C, Wang Y, Zhang X,
Li Y and Mulati: Aidi injection combined with FOLFOX4 chemotherapy
regimen in the treatment of advanced colorectal carcinoma. J Can
Res Ther. 10:522014. View Article : Google Scholar
|
|
16
|
Xie G, Cui Z, Peng K, Zhou X, Xia Q and Xu
D: Aidi injection, a traditional Chinese medicine injection, could
be used as an adjuvant drug to improve quality of life of cancer
patients receiving chemotherapy: A propensity score matching
analysis. Integr Cancer Ther. 18:1534735418810792019. View Article : Google Scholar
|
|
17
|
Lu Y, Zhang S, Zhu X, Wang K, He Y, Liu C,
Sun J, Pan J, Zheng L, Liu W, et al: Aidi injection enhances the
anti-tumor impact of doxorubicin in H22 tumor-containing mice. J
Ethnopharmacol. 303:1159682023. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lan HY, An P, Liu QP, Chen YY, Yu YY, Luan
X, Tang JY and Zhang H: Aidi injection induces apoptosis of
hepatocellular carcinoma cells through the mitochondrial pathway. J
Ethnopharmacol. 274:1140732021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang W, Peng W, Li Y, Pan T, Feng F, Xu J
and Zhou X: Network pharmacology and molecular docking analysis on
molecular targets and mechanisms of aidi injection treating of
nonsmall cell lung cancer. Evid Based Complement Alternat Med.
2022:83502182022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lu Y, Liu W, Lv T, Wang Y, Liu T, Chen Y,
Jin Y, Huang J, Zheng L, Huang Y, et al: Aidi injection reduces
doxorubicin-induced cardiotoxicity by inhibiting carbonyl reductase
1 expression. Pharm Biol. 60:1616–1624. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
WHO Classification of Tumours, . Digestive
System Tumours. 1. 5th edition. International Agency for Research
on Cancer; Lyon: 2019
|
|
22
|
American Joint Committee on Cancer, . AJCC
Cancer Staging Manual. 8th edition. Springer; New York, NY:
2017
|
|
23
|
Common Terminology Criteria for Adverse
Events (CTCAE) Version 4.03. 2010.
|
|
24
|
Gao W and Zhang K: Network meta-analysis
of 8 types of traditional Chinese medicine injection combined with
chemotherapy in colorectal cancer treatment. J Cancer Res Clin
Oncol. 149:9823–9838. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hernandez Dominguez O, Yilmaz S and Steele
SR: Stage IV colorectal cancer management and treatment. J Clin
Med. 12:20722023. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Siegel RL, Wagle NS, Cercek A, Smith RA
and Jemal A: Colorectal cancer statistics, 2023. CA A Cancer J
Clin. 73:233–254. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fu AZ, Graves KD, Jensen RE, Marshall JL,
Formoso M and Potosky AL: Patient preference and decision-making
for initiating metastatic colorectal cancer medical treatment. J
Cancer Res Clin Oncol. 142:699–706. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jazieh AR, Abuelgasim KA, Ardah HI,
Alkaiyat M and Da'ar OB: The trends of complementary alternative
medicine use among cancer patients. BMC Complement Med Ther.
21:1672021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen HM, Lai ZQ, Liao HJ, Xie JH, Xian YF,
Chen YL, Ip SP, Lin ZX and Su ZR: Synergistic antitumor effect of
brusatol combined with cisplatin on colorectal cancer cells. Int J
Mol Med. 41:1447–1454. 2018.PubMed/NCBI
|
|
30
|
Lee SM, Choi HC and Hyun MK: An overview
of systematic reviews: Complementary therapies for cancer patients.
Integr Cancer Ther. 18:15347354198900292019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
An P, Lu D, Zhang L, Lan H, Yang H, Ge G,
Liu W, Shen W, Ding X, Tang D, et al: Synergistic antitumor effects
of compound-composed optimal formula from Aidi injection on
hepatocellular carcinoma and colorectal cancer. Phytomedicine.
103:1542312022. View Article : Google Scholar : PubMed/NCBI
|
